Use of quantitative hepatitis B surface antigen levels in the follow-up of HBV-Infected patients with Genotype D

Use of quantitative hepatitis B surface antigen levels in the follow-up of HBV-Infected patients with Genotype D

To determine the role of quantitative HBsAg levels in follow up of chronic HBV treatment and investigate the relationship between qHBsAg, HBV DNA levels and liver histopathology. 74 CHB patients with genotype D visited our Infectious Diseases outpatient clinic were included into the study. Patients...

Full description

Bibliographic Details
Main Authors:	Ergenekon Karagoz, Alpaslan Tanoglu, Vedat Turhan, Mehmet Burak Selek, Asim Ulcay, Hakan Erdem, Ayse Batirel
Format:	Article
Language:	English
Published:	Society of Turaz Bilim 2018-09-01
Series:	Medicine Science
Subjects:	Chronic hepatitis B hepatitis B surface antigen genotype
Online Access:	http://www.ejmanager.com/fulltextpdf.php?mno=286547

Similar Items

Clinical Significance of Neutrophil to Lymphocyte Ratio and Mean Platelet Volume for Predicting the Severity of Hepatic Fibrosis in Patients with Chronic Hepatitis B [Kronik Hepatit B Hastalarinda Karaciger Fibrozisinin Ciddiyetinin Belirlenmesinde Notrofil/Lenfosit Orani ve Ortalama Trombosit Hacminin Klinik Onemi]
by: Alpaslan Tanoglu, et al.
Published: (2016-03-01)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
by: Young-Suk Lim
Published: (2023-01-01)

Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen
by: Mary C. Kuhns, et al.
Published: (2021-10-01)

Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01)

Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis
by: Nghiem Xuan Hoan, et al.
Published: (2021-02-01)

Phylogenetic analysis and genotype distribution of Hepatitis B Virus (HBV) in Roraima, Brazil
by: Débora Dinelly de Sousa, et al.
Published: (2018-07-01)

Hepatitis B Core Antigen Expression in Hepatocytes Reflects Viral Response to Entecavir in Chronic Hepatitis B Patients
Published: (2013-07-01)

Prevalence of antibodies to hepatitis B core antigen in blood donors in the middle west region of Brazil
by: José Ivan Aguiar, et al.
Published: (2001-02-01)

HCV and HBV genotypes: vital in the progression of HCV/ HBV co-infection
by: Yasmin Badshah, et al.
Published: (2025-01-01)

The Coexistence of Hepatitis B Surface Antigen and Anti-HBs in Patients With Chronic HBV Infection: Prevalence and Related Factors
by: Nguyen Thi Cam Huong, et al.
Published: (2023-01-01)

Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
by: Sun Young Yim, et al.
Published: (2017-05-01)

Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital
by: Diksha Budhani, et al.
Published: (2025-01-01)

Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
by: Lung-Yi Mak, et al.
Published: (2023-01-01)

Comparison of Two Enzyme Immunoassays for the Detection of Antibody to Hepatitis B Virus Core Antigen
by: Souto FJD, et al.
Published: (1997-01-01)

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
by: Rani Burm, et al.
Published: (2023-03-01)

A Multivalent mRNA Therapeutic Vaccine Exhibits Breakthroughs in Immune Tolerance and Virological Suppression of HBV by Stably Presenting the Pre-S Antigen on the Cell Membrane
by: Shang Liu, et al.
Published: (2025-02-01)

Circulating HBsAg-specific B cells are partially rescued in chronically HBV-infected patients with functional cure
by: Shuqin Gu, et al.
Published: (2024-12-01)

Prevalence of Hepatitis B genotypes worldwide and in Iran: A meta-analysis
by: Kosar Baghernezhad, et al.
Published: (2023-02-01)

Seroprevalence of Hepatitis Bs antigen among pregnant women visiting primary health care centers in Baghdad Al-Jadeda sector in Baghdad.
by: Shayma S. Ali, et al.
Published: (2018-04-01)

Ivermectin Inhibits HBV Entry into the Nucleus by Suppressing KPNA2
by: Anna Nakanishi, et al.
Published: (2022-11-01)

Comparison of the elecsys HBsAg II assay and the architect assay for quantification of hepatitis B surface antigen in chronic hepatitis B patients
by: Chen-Chih Liao, et al.
Published: (2015-06-01)

The impact of hepatitis B virus (HBV) splicing on HBV replication and disease progression
by: Laura C. McCoullough, et al.
Published: (2024-08-01)

Liver-Derived Cell Transfection Model Efficacy for HBV Genotype B Replication/Transcription Is Determined by Complex Host Transcription Factor Network
by: Roxanne Hui-Heng Chong, et al.
Published: (2021-03-01)

Seroepidemiology of hepatitis B virus (HBV) and relationship to serum transaminase levels in Indian population
by: Manoj Kumar, et al.
Published: (2024-06-01)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
by: Maryam Moini, et al.
Published: (2022-03-01)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
by: Chih-Wei Tseng, et al.
Published: (2022-08-01)

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B
by: Ka-Yin Hui, et al.
Published: (2023-03-01)

Hepatitis B genotyping and its clinical implications
by: Aljarallah Badr
Published: (2006-01-01)

The use of ustekinumab in a patient with severe psoriasis and positive HBV serology
by: Raquel Bissacotti Steglich, et al.
Published: (2014-07-01)

Nucleos(t)ide Analogue Treatment Cessation in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients: A Retrospective Single-center Study
by: Figen SARIGÜL, et al.
Published: (2020-12-01)

Management of Vaccination Failure in a Case of HIV - HBV Co-infection: A Case Report
by: Andre Small, et al.
Published: (2014-06-01)

Management of Vaccination Failure in a Case of HIV -HBV Co-infection: A Case Report
by: Andre Small, et al.
Published: (2014-01-01)

Development of anti-hepatitis B virus core antigen biosensor using gold nanoparticle-decorated reduced graphene oxide
by: Abd Muain, Mohamad Farid
Published: (2019)

Active immunization against hepatitis B virus (HBV) with low-doses of plasma-derived vaccine by intradermal route
by: Flair José Carrilho, et al.
Published: (1989-04-01)

Requirement for further validation on the seroconversion of hepatitis B surface antigen in successful vaccinees
by: Qing-Lei Zeng, et al.
Published: (2021-08-01)

Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
by: Yitbarek Wasihun, et al.
Published: (2024-05-01)

Genetic diversity of HBV in indigenous populations on the border between Brazil and Bolivia
by: Fabianne Araújo Gomes dos Santos Alves, et al.
Published: (2022-09-01)

Prevalence of hepatitis B in dental patients
by: Ashmita Kaur R. Chawla, et al.
Published: (2023-01-01)

Correlation between hepatitis B viral load and hepatitis B surface antigen levels in asymptomatic seropositive blood donors
by: Prashant Pandey, et al.
Published: (2023-01-01)

Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay
Published: (2015-09-01)